U.S. Senate · 118th Congress · S. 2886
Updated Drug Labeling for Patient Safety Act
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Chris Van HollenD-MD
- Introduced
- September 21, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
3 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these